You'll see alot of these brokers upping their SP target but keeping BLY as underperform just to save face. How typical But guess what? they don't need to save face cos they have lost all credibility anyway.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%